FDA Inspection 1107067 — Christopher J. Sweeney, M.B.B.S.
The FDA completed an inspection of Christopher J. Sweeney, M.B.B.S. on October 10, 2019 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 10, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional Details
Clinical Investigator (CI)